OTCMKTS:DGNOF DIAGNOS Q4 2026 Earnings Report $0.34 0.00 (-0.47%) As of 03:34 PM Eastern ProfileEarnings History DIAGNOS EPS ResultsActual EPS-$0.01Consensus EPS -$0.01Beat/MissMissed by -$0.00One Year Ago EPSN/ADIAGNOS Revenue ResultsActual Revenue$0.01 millionExpected Revenue$0.05 millionBeat/MissMissed by -$37.00 thousandYoY Revenue GrowthN/ADIAGNOS Announcement DetailsQuarterQ4 2026Date6/11/2026TimeAfter Market ClosesConference Call DateN/AConference Call TimeN/AUpcoming EarningsDIAGNOS' next earnings date is estimated for Tuesday, December 1, 2026, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile DIAGNOS Earnings HeadlinesDIAGNOS to Hold its Annual General Meeting of Shareholders on September 30, 2026September 14, 2026 | globenewswire.comDIAGNOS Receives Saudi FDA Medical Device License for CARA System, Bringing AI-Assisted Retinal Image Analysis to Saudi ArabiaAugust 13, 2026 | globenewswire.comA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.September 24 at 1:00 AM | Porter & Company (Ad)DIAGNOS Receives Health Canada Medical Device Licence for CARA System, Bringing AI-Assisted Retinal Image Analysis to Canadian OptometristsJuly 27, 2026 | globenewswire.comEmerging Growth Research Releases Flash Report on DIAGNOS, Highlighting Regulatory Catalysts and Commercialization Potential for CARA AI PlatformJune 5, 2026 | globenewswire.comDIAGNOS to Present at the Emerging Growth Conference on June 10, 2026June 3, 2026 | globenewswire.comSee More DIAGNOS Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like DIAGNOS? Sign up for Earnings360's daily newsletter to receive timely earnings updates on DIAGNOS and other key companies, straight to your email. Email Address About DIAGNOSDIAGNOS (OTCMKTS:DGNOF) is a Canadian healthcare technology company focused on the early detection of medical conditions through artificial intelligence, image processing and telemedicine. The company develops and commercializes tools designed to help healthcare providers identify disease at an earlier stage and support access to diagnostic services. Its principal platform, CARA (Computer Assisted Retinal Analysis), analyzes retinal images to assist with the screening of conditions such as diabetic retinopathy and other eye diseases. DIAGNOS has also developed related screening and remote-care capabilities intended to support patient assessment in clinics, pharmacies and other healthcare settings. Founded in 1998 and headquartered in Brossard, Quebec, DIAGNOS has pursued commercial and screening initiatives in Canada and international markets. The company’s solutions are designed for use by healthcare organizations seeking scalable, technology-assisted screening and telemedicine services.View DIAGNOS ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks3 Restaurant Stocks Near 52-Week Lows as Consumer Pressure BuildsPaychex Plunges, Providing the Entry Investors Have Been Waiting ForThe Case for Buying High-Yield General Mills Just StrengthenedEnergy Transfer Taps the AI Power BoomFull Throttle: Kratos and GE Fire Up a Next-Gen Defense EngineSandisk Joins the S&P 100—Is the Index Flow, or the AI Story, Driving the Stock? Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
